Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIP-SICKLE aspirin prevention trial in sickle cell pregnancy
PACTR202001787519553Recruiting
- Sponsor
- Tertiary Education Trust Fund
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in preeclampsia and intrauterine growth restriction (IUGR) comparing Low-dose aspirin with Placebo (2 arms). Primary endpoint: Composite adverse fetal outcome. Started Jan 2020; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on PACTR202001787519553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001787519553.